StemGen, Inc.
SGNI
$0.10
$0.06150.00%
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | 20.00K | -- | 0.00 | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 20.00K | -- | 0.00 | -- |
| Cost of Revenue | 4.20K | 12.80K | -- | -5.00K | 5.10K |
| Gross Profit | -4.20K | 7.20K | -- | 5.00K | -5.10K |
| SG&A Expenses | 149.90K | 28.80K | 77.00K | 36.50K | 33.30K |
| Depreciation & Amortization | 18.10K | 18.80K | 18.10K | 61.00K | 18.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 172.20K | 60.50K | 95.10K | 92.50K | 57.30K |
| Operating Income | -172.20K | -40.50K | -95.10K | -92.50K | -57.30K |
| Income Before Tax | -185.80K | -81.40K | -136.00K | -133.40K | -98.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -185.80K | -81.40K | -136.00K | -133.40K | -98.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -185.80K | -81.40K | -136.00K | -133.40K | -98.20K |
| EBIT | -172.20K | -40.50K | -95.10K | -92.50K | -57.30K |
| EBITDA | -154.10K | -21.60K | -77.00K | -31.50K | -38.50K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 45.67M | 45.67M | 45.67M | 45.39M | 45.67M |
| Average Diluted Shares Outstanding | 45.67M | 45.67M | 45.67M | 45.39M | 45.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
